Breast cancers that are ER-negative tend to grow more quickly than ER-positive cancers. They are also less likely to respond to hormonal therapies such as tamoxifen or aromatase inhibitors. Consequently, other treatment options such as chemotherapy, targeted therapy, and radiation may be more appropriate for managing ER-negative breast cancer.
